Attached files

file filename
EX-31 - EXHIBIT 31 - Phoenix Life Sciences International Limited.medijane10k15ex31.htm
10-K - FORM 10-K - Phoenix Life Sciences International Limited.mjmd10k15v10.htm

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of MediJane Holdings Inc. (the "Company") on Form 10-K for the year ended February 28, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Lewis “Spike” Humer, Interim Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


            (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


            (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/Lewis “Spike” Humer

Lewis “Spike” Humer

Interim Chief Executive Officer


July 28, 2015



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of MediJane Holdings Inc. (the "Company") on Form 10-K for the year ended February 28, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Russel Stone, Interim Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:


            (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


            (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


/s/Russell Stone

Russell Stone

Interim Chief Financial Officer


July 28, 2015